BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 "更广"。

路透中文

Apr 13

BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 "更广"。

4月13日 - ** Telix Pharmaceuticals TLX.AX上涨8.8%至15.93澳元，创2025年11月5日以来新高

** 股价创下 3 月 10 日以来最大盘中涨幅

** 生物制药巨头和生物技术公司 Regeneron Pharmaceuticals REGN.O 宣布在 (link) 开展合作，共同开发放射性药物疗法并将其商业化

** Telix公司称将从Regeneron公司获得4,000万美元，并可能获得高达21亿美元的付款和特许权使用费

** 花旗银行称，合作范围可能很 "广泛"；并补充说，合作可能不仅限于放射研究

** 股票平均评级为 "买入"；根据伦敦证券交易所集团汇编的数据，PT 中位数为 23.15 澳元

** 截至目前，TLX上涨了38.8%。

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2627860483"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2627860483\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2627860483?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-04-13 10:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2627860483","market":"us","top_or_hot":-1,"title":"BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。</title></head><body><p>\n<span>4月13日</span><span> - </span>** <a href=\"https://laohu8.com/S/TLX.AU\">Telix Pharmaceuticals</a> <span>TLX.AX</span>上涨8.8%至15.93澳元，创2025年11月5日以来新高</p><p>** 股价创下 3 月 10 日以来最大盘中涨幅</p><p>** <a href=\"https://laohu8.com/S/000504\">生物</a>制药巨头和生物技术公司 Regeneron Pharmaceuticals <span>REGN.O</span> 宣布在 (<span>link</span>) 开展合作，共同开发放射性药物疗法并将其商业化</p><p>** Telix公司称将从Regeneron公司获得4,000万美元，并可能获得高达21亿美元的付款和特许权使用费</p><p>** 花旗银行称，合作范围可能很 \"广泛\"；并补充说，合作可能不仅限于放射研究</p><p>** 股票平均评级为 \"买入\"；根据<a href=\"https://laohu8.com/S/LSE.UK\">伦敦证券交易所</a>集团汇编的数据，PT 中位数为 23.15 澳元</p><p>** 截至目前，TLX上涨了38.8%。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-04-13 10:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。</title></head><body><p>\n<span>4月13日</span><span> - </span>** <a href=\"https://laohu8.com/S/TLX.AU\">Telix Pharmaceuticals</a> <span>TLX.AX</span>上涨8.8%至15.93澳元，创2025年11月5日以来新高</p><p>** 股价创下 3 月 10 日以来最大盘中涨幅</p><p>** <a href=\"https://laohu8.com/S/000504\">生物</a>制药巨头和生物技术公司 Regeneron Pharmaceuticals <span>REGN.O</span> 宣布在 (<span>link</span>) 开展合作，共同开发放射性药物疗法并将其商业化</p><p>** Telix公司称将从Regeneron公司获得4,000万美元，并可能获得高达21亿美元的付款和特许权使用费</p><p>** 花旗银行称，合作范围可能很 \"广泛\"；并补充说，合作可能不仅限于放射研究</p><p>** 股票平均评级为 \"买入\"；根据<a href=\"https://laohu8.com/S/LSE.UK\">伦敦证券交易所</a>集团汇编的数据，PT 中位数为 23.15 澳元</p><p>** 截至目前，TLX上涨了38.8%。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4T40W04L:1","article_id":"2627860483","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2627860483","pubTimestamp":1776047956,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4588":"碎股","LU2237438978.USD":"Amundi Funds US Pioneer A2 (C) USD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK7067":"生物科技","REGN":"再生元制药公司","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0058720904.USD":"联博国际健康护理基金A","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BK4585":"ETF&股票定投概念","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","BK4139":"生物科技","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU0882574055.USD":"富达全球健康医疗A ACC","TLX.AU":"TELIX PHARMACEUTICALS LTD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU1917777945.USD":"安联专题基金Cl AT Acc"},"translate_title":"BUZZ-Australia's Telex Pharmaceuticals Gains on $40M Regeneron Deal; Citibank thinks the deal is \"broader\".","themeId":"37684715aaf54a73b9fe52ee56a263cc","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TLX.AU":0.9,"REGN":0.9},"content_text":"BUZZ-澳大利亚泰利克斯制药公司因 4,000 万美元的再生元交易而上涨；花旗银行认为交易范围 \"更广\"。\n4月13日 - ** Telix Pharmaceuticals TLX.AX上涨8.8%至15.93澳元，创2025年11月5日以来新高** 股价创下 3 月 10 日以来最大盘中涨幅** 生物制药巨头和生物技术公司 Regeneron Pharmaceuticals REGN.O 宣布在 (link) 开展合作，共同开发放射性药物疗法并将其商业化** Telix公司称将从Regeneron公司获得4,000万美元，并可能获得高达21亿美元的付款和特许权使用费** 花旗银行称，合作范围可能很 \"广泛\"；并补充说，合作可能不仅限于放射研究** 股票平均评级为 \"买入\"；根据伦敦证券交易所集团汇编的数据，PT 中位数为 23.15 澳元** 截至目前，TLX上涨了38.8%。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}